Skip to content

Promoting Radon Testing Among Mothers of Young Children

Promoting Radon Testing Among Mothers of Young Children: A Translational Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07591389
Enrollment
100
Registered
2026-05-15
Start date
2026-04-10
Completion date
2026-12-01
Last updated
2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer (Diagnosis)

Brief summary

Radon is the second-leading cause of lung cancer after smoking and may contribute to other cancer deaths; children are especially vulnerable due to a larger lung surface area and higher respiratory rates. The goal of this research is to test the feasibility of the radon app to promote radon testing among mothers of children aged 4 or younger when they receive a free radon test kit.

Detailed description

This feasibility study enrolls mothers of children under age 4 who receive a free short-term radon test kit. Participants are introduced to and given access to a smartphone radon app designed to deliver targeted education, step-by-step testing instructions, reminders, and social-sharing prompts. The study measures cognitive outcomes (radon knowledge, self-efficacy for testing, and response efficacy beliefs) before and after app exposure, and behavioral outcomes (whether the test kit is completed and returned for lab analysis, and whether participants share radon information or recommend testing to others). Data collection combines brief baseline and follow-up surveys, app usage analytics (e.g., time in app, modules completed, reminder interactions), and laboratory confirmation of returned kits. Feasibility metrics include recruitment and retention rates, app engagement, and kit return rates.

Interventions

BEHAVIORALThe radon app

Participants will be asked to use the radon app.

Sponsors

University of North Dakota
Lead SponsorOTHER
National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participants are female mothers of children aged 4 and under. * Participants own a smartphone. * Children brought in for appointments are their biological or adoptive child.

Exclusion criteria

* Previous testing for radon within the past two (2) years. * The mother's child brought in for the appointment is over 4 years of age.

Design outcomes

Primary

MeasureTime frameDescription
T1 (baseline: pre-exposure survey, distribution of free radon test kit)Initial Enrollment to 2 months after enrollmentT1 (baseline: pre-exposure survey, distribution of free radon test kit). The pre-expsosure survey will measure: Primary endpoints: (1) Radon knowledge, 20 true/false items); (2) self-efficacy, response efficacy, and sharing intention (7-point Likert).
T2 (post-exposure survey at 2 months)2 months after enrollmentT2 refers to the time point where participants will complete the post-exposure survey, which will happen two months after T1. The primary endpoints are: (1) Changes in radon knowledge from T1 to T2, as measured by the number of correct responses to a series of 20 true/false questions (e.g., "The EPA recommends that homes with 4 picocuries per liter (pCi/L) or more of radon should be fixed."); (2) Changes in self-efficacy, response efficacy, and sharing intention from T1 to T2, measured by 7-point Likert scales; (3) Radon information shared with others and recommended to others to test their houses for radon from T1 to T2. It will be measured by a series of yes/no questions. Analyses: Aim 1-directional dependent t-tests for mean changes; McNemar's test for paired proportions of sharing.
T3 (end of kit tracking at 4 months)4 months after last enrollmentNumber of radon test kits used and returned to the laboratory by participants. Directional McNemar's test for kit return proportions T1 vs T3.

Countries

United States

Contacts

CONTACTSoojung Kim Interim Dean, School of Graduate Studies, PhD, MPH
soojung.kim@UND.edu701-777-2786

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026